Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease

OBJECTIVES: Multiple sclerosis (MS) is a neurodegenerative disease characterised by inflammation and damage to the myelin sheath, resulting in physical and cognitive disability. There is currently no cure for MS, and finding effective treatments to prevent disease progression has been challenging. R...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Transl Immunology
Päätekijät: Denny, Lisa, Al Abadey, Afnan, Robichon, Katharina, Templeton, Nikki, Prisinzano, Thomas E, Kivell, Bronwyn M, La Flamme, Anne C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7811802/
https://ncbi.nlm.nih.gov/pubmed/33489124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1234
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia